Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today announced …
Needham & Company analyst Alan Carr weighs in with a few insights on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after hosting a meeting with Doug Dieterich, MD and Alyson Harty, …
Facebook Inc Facebook Inc (NASDAQ:FB) has added some new features to its Facebook Live to give people “more ways to discover, share, and interact …
Merrill Lynch’s healthcare analyst Ying Huang weighed in on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after the FDA advisory committee unanimously recommended approval of the company’s liver drug. The …
The iShares Nasdaq Biotechnology ETF (IBB) is poised to open higher on Friday, boosted by Federal Reserve Chair Janet Yellen’s positive comments on the economy. Among …
Healthcare analysts weigh in on drug makers Relypsa Inc (NASDAQ:RLYP) and Intercept Pharmaceuticals Inc (NASDAQ:ICPT), as one explores potential sale and the other gets closer to FDA …
Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, …
Leerink and Wedbush analysts highlight potential catalysts for Intercept Pharmaceuticals Inc (NASDAQ:ICPT) and bluebird bio Inc (NASDAQ:BLUE). One analyst believes that better than expected briefing …
Valeant Pharmaceuticals Intl Inc Shares of Valeant Pharmaceuticals are rising nearly 10% today, after the company announced that an Ad Hoc Committee has completed its review …
Twitter Inc (NYSE:TWTR) is up over 2% in pre-market trading after Bloomberg reported that it will broadcast NFL games online on Thursday nights. …
